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Abstract
Background Hundreds of thousands of surgical arthros-
copy procedures are performed annually in the United
States (US) based on MRI findings. There are situations
where these MRI findings are equivocal or indeterminate
and because of this clinicians commonly perform the
arthroscopy in order not to miss pathology. Recently, a less
invasive needle arthroscopy system has been introduced
that is commonly performed in the physician office setting
and that may help improve the accuracy of diagnostic
findings. This in turn may prevent unnecessary follow-on
arthroscopy procedures from being performed.
Objective The purpose of this analysis is to determine
whether the in-office diagnostic needle arthroscopy system
can provide cost savings by reducing unnecessary follow
on arthroscopy procedures.
Methods Data obtained from a recent trial and from a
systematic review were used in comparing the accuracy of
MRI and VisionScope needle arthroscopy (VSI) with
standard arthroscopy (gold standard). The resultant false
positive and false negative findings were then used to
evaluate the costs of follow-on procedures. These differ-
ences were then modeled for the US patient population
diagnosed and treated for meniscal knee pathology (most
common disorder) to determine if a technology such as VSI
could save the US healthcare system money. Data on sur-
gical arthroscopy procedures in the US for meniscal knee
pathology were used (calendar year [CY] 2010). The costs
of performing diagnostic and surgical arthroscopy proce-
dures (using CY 2013 Medicare reimbursement amounts),
costs associated with false negative findings, and the costs
for treating associated complications arising from diag-
nostic and therapeutic arthroscopy procedures were
assessed.
Results In patients presenting with medial meniscal
pathology (International Classification of Diseases, 9th
edition, Clinical Modification [ICD9CM] diagnosis 836.0),
VSI in place of MRI (standard of care) resulted in a net cost
savings to the US system of US$115–US$177 million (CY
2013) (use of systematic review and study data, respec-
tively). In patients presenting with lateral meniscus
pathology (ICD9CM 836.1), VSI in place of MRI cost the
healthcare system an additional US$14–US$97 million
(CY 2013). Overall aggregate savings for meniscal (lateral
plus medial) pathology were identified in representative
care models along with more appropriate care as fewer
patients were exposed to higher risk surgical procedures.
Conclusions Since in-office arthroscopy is significantly
more accurate, patients can be treated more appropriately
and the US healthcare system can save money, most
especially in medial meniscal pathology.
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Key Points for Decision Makers
Diagnostic accuracy is improved with in-office
arthroscopy using VisionScope imaging (VSI) versus
MRI.
Fewer patients would go on to more invasive
surgical procedures if VSI were used, and fewer
patients would be exposed to unnecessary care.
With less unnecessary care, there is the potential for
significant cost savings in using VSI.
1 Background
Magnetic resonance imaging (MRI) plus clinical evalua-
tion is the standard of care (hereafter referred to as MRI)
for assessing soft tissue injuries in the knee joint. However,
MRI assessment has drawbacks: a high incidence of false
positive (FP) (lesion shown to be present when in actuality
there is none) and false negative (FN) (lesion shown to be
negative when there is one) findings. These FPs and FNs
occur most commonly with deep intra-articular structures
such as the medial and lateral meniscus or cartilage of the
knee. In the United States (US), for the year 2010, 502,000
surgical arthroscopic procedures were performed on the
medial meniscus/cartilage of the knee, and 192,000 for the
lateral meniscus/cartilage of the knee [1] (Table 1). Both of
these procedures, combined, represent close to 50 % of all
surgical arthroscopic procedures (Table 1). Medial and
lateral meniscal tears are commonly the hardest pathology
to diagnose accurately [2]. Further, clinicians view MRI
findings with skepticism based on their underestimating
intra-articular defects [3–5]. Due to equivocal findings with
MRI, physicians commonly perform surgical arthroscopy.
This is reflected in the US statistics that show 99 % of
arthroscopies performed are therapeutic in nature [6]. An
alternative diagnostic modality might mitigate some of the
above issues.
Small bore (needle arthroscopy) has been available for a
number of years and its efficacy is well established. The
results reported in the literature have demonstrated similar
accuracy to standard, larger sized arthroscopes [7–17]. A
newer and smaller bore arthroscope with improved optics
and visualization, the VisionScope system (VSI), was
recently introduced into the office setting for pre- and post-
operative imaging and diagnostics. The key component of
this system is a proprietary 1.4-mm-diameter semi-rigid/
fiber lens with 2-mm portal/trocar endoscope system, a size
comparable to arthrocentesis needles. This is accomplished
without having to extend the knee joint with fluid (for
purposes of visualization) through a second access site.
To date, no one has examined the economic effect of a
more widespread use of office-based needle arthroscopy.
The purpose of this analysis is to use the findings from a
recent comparison study of VSI and MRI compared with
standard arthroscopy (used as the gold standard) and; of
published meta-analysis MRI findings, [18] in examining
the overall costs to the US healthcare system. The
hypothesis is that with the use of the VSI office arthroscopy
system, considerable savings to the healthcare system can
be realized and the quality of care can be improved.
2 Methods
2.1 Data Sources and Methods
The National Survey Ambulatory Surgery 2010 (NSAS)
[1], conducted periodically by the National Center for
Health Statistics (NCHS), covers ambulatory surgery pro-
cedures performed in hospitals and freestanding ambula-
tory surgery centers in the US. The hospital universe
includes noninstitutional hospitals exclusive of Federal,
military, and Department of Veterans Affairs hospitals.
Sensitivity and specificity estimates for VSI and MRI
plus clinical diagnoses were derived from a recent study
comparing both with standard arthroscopy (the gold stan-
dard) (see electronic supplementary material [ESM],
Appendix 1) (defined as the community setting case) and
from published systematic reviews comparing MRI with
standard arthroscopy [19] (defined as the academic medical
center setting case).
Costs for diagnostic and treatment paradigms using
current methods and for the VSI were Medicare’s 2013
national average actual reimbursement rates for each pro-
cedure (unless otherwise specified). Costs were calculated
for both MRI and VSI positive and negative findings.
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Estimates for complications (morbidity and mortality)
from each diagnostic method and for treatment were
derived from the literature.
Estimates of the number of diagnoses which were con-
sidered true positives (TPs), true negatives (TNs), FPs and
FNs for both VSI and MRI, plus clinical diagnoses were
made by using the actual number of procedures performed
for both medial and lateral meniscus tears, found in
Table 1. Since the standard of care for diagnosis of knee
pathology is considered MRI plus clinical diagnosis, the
number of procedures performed in 2010 for medial and
lateral meniscus procedures were fed into a sensitivity,
specificity, positive and negative predictive value table
using the values obtained from the study found in
Appendix 1 and from systematic review findings, also in
Appendix 1 (see ESM). Further, since the number of pro-
cedures in 2010 could be considered a combination of TP
and FP findings, FN and TN findings were derived from
these amounts. These were then used as the base case and
are identified in Table 2 (MRI medial meniscus) and
Table 3 (MRI lateral meniscus). Using these values one
could then calculate the total number of negative findings
from MRI and consequently all diagnostics performed
(negative diagnostics ? positive diagnostics) that yielded
the actual CY 2010 surgical arthroscopy procedure num-
ber. From these findings, the number of cases which
actually had either medial or lateral meniscus pathology
(i.e., sum of TPs and FNs—pathology that should be
positive for a lesion; ‘actual number’) was derived. This
‘actual number’ was then fed into a similar table using VSI
as the diagnostic. The ‘actual number’ was used to derive
TPs, FPs, TNs, and FNs for VSI, based on study-derived
VSI sensitivity and specificity values (Appendix 1, ESM).
Again, these numbers were used to calculate all the diag-
nostics performed to yield a surgical number (hypothetical
VSI number of surgeries (TPs ? FPs) if one was to use
VSI in place of MRI (Table 4 [VSI medical meniscus] and
Table 5 [VSI lateral meniscus]). All diagnostic and thera-
peutic numbers were then fed into a cost model to deter-
mine the overall effect on all costs (of diagnostics plus
resultant treatments) using either MRI or VSI diagnostics
on the US healthcare system.
2.2 Direct Cost Calculation
The following diagnostic and treatment paradigms were
used for both current (MRI) and VSI (all assumed to be
performed in either the physician office or outpatient set-
tings): International Classification of Diseases, 9th edition,
Clinical Modification (ICD9CM) 836.0 (diagnosis of tear
of medial cartilage or meniscus of knee); ICD9CM 836.1
(diagnosis tear of lateral cartilage or meniscus of knee).
The costs for these diagnoses and treatment, including
complications (morbidity and mortality) arising from the
procedure, were assessed over an acute time period (from
initial diagnosis, through the follow-up visit post-proce-
dure) in the following manner (using CY 2013 Medicare
reimbursement information).
MRI: orthopedic consult (using current procedural ter-
minology [CPT] 99203—evaluation and management
[E&M] for a new patient) ? X-ray (CPT 73560—radio-
logic exam) ? MRI (CPT 73721—MRI of any lower
Table 1 Surgical arthroscopy
procedures related to meniscal
tears 2010—with diagnosis (Dx)
listed as primary diagnosis
Source: National Ambulatory








Description Procedure Number of
procedures
Medial meniscus/cartilage
8360 Medial meniscus/cart tears 80.26 (surgical knee
arthroscopy)
320,156








Total medial meniscus/cartilage procedures 502,219
Lateral meniscus/cartilage
8361 Lateral meniscus/cartilage tears 80.26 (surgical knee
arthroscopy)
158,864
8361 Lateral meniscus/cartilage tears 81.47 (repair torn
meniscus)
29,305






Total all surgical knee
arthroscopies
1,450,746
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extremity joint—global) ? MRI (CPT 73721-26—MRI
any lower extremity joint—professional) ? arthrocentesis
(CPT 20610—aspiration or injection of a major joint at
10 % of time [20]) ? Hospital Outpatient Arthroscopy
(assumes a meniscectomy was performed when a patient
was diagnosed for pathology [i.e., a TP or FP]—CPT
29881) ? follow-up orthopedic consult (CPT 99213—
E&M for existing patient).
VSI: orthopedic consult (using CPT 99203—E&M
for a new patient) ? X-ray (CPT 73560—radiologic
exam) ? VSI (CPT 29870 nonfacility) ? Hospital Out-
patient Arthroscopy (assumes a meniscectomy was
Table 2 Medial meniscus MRI versus arthroscopy (blinded)—MRI (community)
Blinded refers to the reader’s (radiologist) assessment of the MRI and the fact that they were blinded to prior radiological readings and surgical
notes
Community refers to the care setting with the MRI and VSI readings occurring in a community hospital setting versus academic medical center
FN false negative, FP false positive, NAMCS National Ambulatory Medical Care Survey, NHAMCS National Hospital Ambulatory Medical Care
Survey, NPV negative predictive values, PPV positive predictive values, TN true negative, TP true positive
Table 3 Lateral meniscus MRI versus arthroscopy (blinded)—MRI (community)
Blinded refers to the reader’s (radiologist) assessment of the MRI and the fact that they were blinded to prior radiological readings and surgical
notes
Community refers to the care setting with the MRI and VSI readings occurring in a community hospital setting versus academic medical center
FN false negative, FP false positive, NAMCS National Ambulatory Medical Care Survey, NHAMCS National Hospital Ambulatory Medical Care
Survey, NPV negative predictive values, PPV positive predictive values, TN true negative, TP true positive
Table 4 Medial meniscus VSI versus arthroscopy (surgeon) (community)
Community refers to the care setting with the MRI and VSI readings occurring in a community hospital setting versus academic medical center
Surgeon refers to the readings being performed by a surgical arthroscopist
FN false negative, FP false positive, NAMCS National Ambulatory Medical Care Survey, NHAMCS National Hospital Ambulatory Medical Care
Survey, NPV negative predictive values, PPV positive predictive values, TN true negative, TP true positive, VSI VisionScope imaging
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performed when a patient was diagnosed for pathology
[i.e., a TP or FP]—CPT 29881) ? follow-up orthopedic
consult (CPT 99213—E&M for existing patient).
The costs for each of the above services/procedures,
using CY 2013 Medicare reimbursement data (Table 6),
include the following:
Overlay of the incidence and costs for complications
associated with each procedure above and treated in the
appropriate care setting. The complications evaluated were
those seen with standard arthroscopy. The complication
rates used for knee arthroscopy were derived from a recent
article (2011) appearing in the Journal of Bone and Joint
Surgery [21] (Table 7). Since the VSI disposable arthro-
scope is similar in size to needles used in arthrocentesis, the
complication rates applied to the costs of diagnostic knee
arthroscopy using VSI were derived from the literature
based on the types of complications seen with arthrocentesis
(Table 7), or from the assumption that since only one portal
is necessary in VSI, complications were cut in half over
standard arthroscopy (one portal versus two portals).
FN results on MRI and VSI were assumed to be treated
first via physical therapy (PT) (CPT 97110, twice per week
for 6 weeks [22] and at an adherence rate/attendance of
86 % [23] of these visits or 10.3 visits [12 9 0.86]) and then
via an arthroscopic procedure based on crossover rates from
randomized controlled trials [22, 24]. The PT sessions as per
above are consistent with how private payers such as CIGNA
cover and pay for PT [25]. This cross over from PT to a
therapeutic arthroscopy procedure was estimated at 30 % for
the knee [22]. If PT crossed over to a therapeutic procedure,
the procedural codes used for the knee were CPT 29881,
APC 0041, and CPT 99213. PT was assumed to occur for
85 % of patients, with an assumption that 15 % did not have
insurance [26] and that lack of insurance was a predisposing
factor to not undergoing PT [27]. The number of sessions
(10.3 over a 6-week period) was reflective of this [23].
TPs and FPs on MRI and VSI were assumed to undergo
PT after a surgical arthroscopy procedure, and FN cross-
over (FN CO) patients who underwent surgery were also
assumed to undergo PT with the same number of PT ses-
sions as per above.
This analysis reflects the direct costs of care (i.e., using a
third-party payer perspective [Medicare]) and does not
examine the societal or individual costs incurred.
3 Results
3.1 Knee Arthroscopies Analysis of MRI versus VSI
3.1.1 For Medial Meniscus
Based on the sensitivity, specificity, and positive and
negative predictive values obtained from the study found in
Table 5 Lateral meniscus VSI versus arthroscopy (surgeon) (community)
Community refers to the care setting with the MRI and VSI readings occurring in a community hospital setting versus academic medical center
Surgeon refers to the readings being performed by a surgical arthroscopist
FN false negative, FP false positive, NAMCS National Ambulatory Medical Care Survey, NHAMCS National Hospital Ambulatory Medical Care
Survey, NPV negative predictive values, PPV positive predictive values, TN true negative, TP true positive, VSI VisionScope imaging
Table 6 Cost inputs used in diagnostic and therapeutic procedures




CPT 99203 E&M new patient—30 minutes
(NF)
108.19
CPT 73560 X-ray knee—one or two views 32.32
CPT 73721 MRI knee—global 405.21
CPT 73721-25 MRI knee—professional 66.69
CPT 29870 Diagnostic knee arthroscopy (NF) 603.23
CPT 29881 Meniscectomy (facility) 551.51
APC 0041 Outpatient knee arthroscopy 2,111.62
CPT 99213 E&M existing patient—30
minutes (NF)
72.81
CPT 97110 Therapeutic procedures,
15 minutes each, PT
31.98
CPT 20610 Arthrocentesis—major joint 65.56
APC Ambulatory Payment Classification, CPT Current Procedural
Terminology, CY calendar year, E&M evaluation and management,
NF nonfacility, PT physical therapy
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Appendix 1 (ESM), it was found that in order for 502,200
surgical arthroscopic procedures to be performed (both TP
[395,734] and FP [106,466] MRI findings), 258,250 neg-
ative findings for MRI also resulted (both FNs and TNs).
The incidence of positive and negative MRI diagnosis and
resultant treatment of this condition therefore totaled
760,450 (502,200 ? 258,250) patients. Expressed differ-
ently, 760,450 patients underwent an MRI in order to
perform these 502,200 surgical arthroscopy procedures.
Further, it was shown that those patients who actually had
disease (i.e., TP ? FN) totaled 486,757 patients (Table 2).
This amount of actual disease was then fed into the VSI
model to compute numeric values for TP, FP, TN, and FN
(Table 4) based on the sensitivities and specificities as
found in the study appearing in Appendix 1 (ESM). This
resulted in the following values calculated: 459,499
TPs ? 9,032 FPs = 468,531, which equals the number of
likely surgical procedures that would be performed based
on positive VSI findings and 291,919 negative findings
(both FN and TN). Thus, the total number of positive and
negative VSI findings and resultant treatment totaled
760,450 patients (468,531 ? 291,919). Expressed differ-
ently, 760,450 patients underwent a VSI diagnostic
arthroscopy in order to perform 468,531 surgical arthros-
copy procedures.
3.1.2 For Lateral Meniscus
Based on the sensitivity, specificity, and positive and
negative predictive values obtained from the study found in
Appendix 1 (ESM), it was found that in order for 192,177
surgical arthroscopic procedures to be performed (both TP
[132,602] and FP [59,575] MRI findings), 444,677 nega-
tive findings for MRI also resulted (both FNs and TNs).
The incidence of positive and negative MRI diagnosis and
resultant treatment of this condition therefore totaled
636,854 (192,177 ? 444,667) patients. Expressed differ-
ently, 636,854 patients underwent an MRI in order to
perform these 192,177 surgical arthroscopy procedures.
Further, it was shown that those patients who actually had
disease (i.e., TP ? FN) totaled 198,804 patients (Table 3).
This amount of actual disease was then fed into the VSI
model to compute values for TP, FP, TN and FN (Table 5)
based on the sensitivities and specificities as found in the
study appearing in Appendix 1 (ESM). This resulted in the
following values calculated: 179,918 TPs ? 18,886
FPs = 198,804, which equals the number of likely surgical
procedures that would be performed based on VSI findings
and 438,051 negative VSI findings (both FN and TN). Thus
the total number of positive and negative VSI findings
totaled 636,854 patients (198,804 ? 438,051).
3.2 Cost Analysis
For medial meniscal tears, the overall cost savings to the
healthcare system equated to US$177 million (Table 8).
The main reason for these savings was that significantly
fewer patients with VSI were exposed to follow-on surgical
treatment from the FP findings seen with MRI. For lateral
meniscal tears, the use of VSI versus MRI cost the
healthcare system marginally more (US$14 million)
(Table 8). However, it should be noted that more people
were treated appropriately with VSI, as VSI resulted in
improved accuracy of diagnosis versus MRI. Thus, these
additional costs should be considered in the light of more
appropriate care being provided. (For more details on the
costs see Appendices 2 and 3 in the ESM). Figures 1, 2, 3
and 4 graphically depict cost of diagnosis and treatment).
In examining the overall cost of VSI versus MRI and
using systematic review findings (defined as the ‘academic
setting’) for TP, FP, FN, and TN, it was found that overall
savings to the system in using VSI was US$115 million for
medial meniscus tears (Table 8). Additionally, using sys-
tematic review data for MRI in assessing lateral meniscus
tears, it was found that using VSI in lieu of MRI cost the
healthcare system an additional US$97 million (Table 8).
Again it should be noted that based on the improved
accuracy of the VSI versus MRI, the additional cost in
Table 7 Complications, incidence, and costs for diagnostic knee arthroscopy
Complication Incidence Cost for treatment (CY 2013)—Medicare
Re-operation
(any reason, including infection)
0.30 % (3 out of 1,000) [21] CPT 29871 (surgical, for infection, lavage and drainage): US$521.91
APC 0041(knee arthroscopy/drainage): US$2,111.62
VTE—unspecified 0.19 % (1.9 out of 1,000) [21] Costs over a 12-month timeframe for treating VTE [37]: US$14,865
DVT 0.12 % (1.2 out of 1,000) [21] Costs over a 12-month timeframe for treating DVT [37]: US$14,865
PE 0.08 % (0.8 out of 1,000) [21] Costs over a 12-month timeframe for treating PE [37]: US$22,900
Infection 0.01 % (1 out of 10,000) [38] CPT 29871 (surgical, for infection, lavage and drainage): US$521.91
APC 0041(knee arthroscopy/drainage): US$2,111.62
APC Ambulatory Payment Classification, CPT Current Procedural Terminology, CY calendar year, DVT deep vein thrombosis, PE pulmonary
embolism, VTE venous thromboembolism
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using VSI in place of MRI was mainly for more appro-
priate care.
A sensitivity analysis was performed on the medial and
lateral meniscus findings (varying the sensitivity and
specificity of MRI findings of the ‘academic setting’ or
systematic review findings) while keeping the VSI sensi-
tivity and specificity findings constant. These were then fed
into the cost models (as shown in Appendix 2 [for medial
meniscus] and Appendix 3 [for lateral meniscus] in the
ESM). The costs findings for the medial meniscus analysis
can be seen in Table 9. What these findings show is that
with improved specificity (i.e., a lower incidence of FP
findings), MRI can be cost saving versus VSI. What the
Table 9 sensitivity analysis also demonstrates is that with
improved specificity and decreased sensitivity (i.e., fewer
FPs but an increase in FNs) for MRI, cost savings are
greatest with MRI. Additionally, a sensitivity analysis was
performed using ‘community setting’ medial meniscus data
(i.e., study data) and examined the following variables that
could affect cost savings: costs of the procedures ±20 %;
number of procedures performed annually ±20 %; sensi-
tivity ±10 % while keeping specificity constant; specificity
±10 % while keeping sensitivity constant; and examining
the same incidence of complications between the VSI and
MRI treatment paths. This analysis is shown in a tornado
plot (Fig. 5). What the tornado plot shows is that the cost
savings are most affected by a ±10 % variation of the
sensitivity of the MRI test from the study value of 81 %
(holding specificity constant at the 61 % study value).
What the tornado plot also confirms is that the cost savings
in using VSI versus MRI in medial meniscus pathology are
robust to significant changes in MRI accuracy, number of
procedures performed, a higher incidence of complications
seen with MRI, and costs of procedures.
4 Discussion
The value of a diagnostic test should be evaluated by how it
affects a patient’s health [28]. What this analysis demon-
strates is not only a cost saving with VSI but less exposure to
unnecessary care with VSI, based on the relative inability of
MRI to rule out and rule in pathology when compared with
VSI. The relative inability of MRI to rule out pathology (i.e.,
a FP finding) can result in follow-on surgical procedures that
are unnecessary. Further, the inability of MRI to rule in
pathology (i.e., missing pathology when it actually is pres-
ent, or an FN finding) may send a patient down a path where
their condition worsens and results in more expensive
treatment, or results in worsening of a patient’s quality of
life due to prolonged pain and suffering. In this cohort of
patients with likely disease (based on the study design as
outlined in Appendix 1, ESM), it was found that, in patients
who actually had (TP ? FN) medial or lateral meniscus
knee pathology, a significantly lower number of patients
were correctly identified as having disease (i.e., TP) with
MRI versus VSI. As well, based on higher specificity values
associated with using VSI, fewer patients were exposed to
unnecessary procedures (i.e., FP)—thus improving quality
of care. This resulted in significant cost savings to the
healthcare system totaling US$163 million (US$177 million
[medial meniscus pathology] ? -US$14 million [lateral
meniscus pathology]) when diagnosis and treatment were
modeled using VSI.
Table 8 Diagnosis and treatment of medial meniscal (MM) and lateral meniscal (LM) tears using MRI and VisionScope imaging (VSI)
(including complications) (community and academic settings)









patient due to exposure
to arthroscopy
procedure ($US)
Total costs to system
(US$ millions); CY 2013
MRI (MM) (community) 760,450 3,575 72 2,718
VSI (MM) (community) 760,450 3,342 45 2,541
Costs savings using VSI 177
MRI (LM) (community) 636,854 2,087 72 1,329
VSI (LM) (community) 636,854 2,110 40 1,343
Cost savings using VSI (14)
MRI (MM) (academic) 760,450 3,529 72 2,682
VSI (MM) (academic) 760,450 3,365 43 2,559
Cost savings using VSI 115
MRI (LM) (academic) 636,854 2,132 72 1,358
VSI (LM) (academic) 636,854 2,285 39 1,455
Cost savings using VSI (97)
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The MRI findings (sensitivities, specificities, and accu-
racies) associated with the study outlined in Appendix 1
(ESM) are slightly worse than those found with meta-
analyses—most especially for deep-seated pathology found
in medial and lateral meniscus/cartilage tears [19, 29].
However, the current finding of a lower level of accuracy
with MRI compared with standard arthroscopy is consistent
with a trend in findings of lower accuracy over time [19]
and with blinding of the clinical assessor (clinical assessor
interpreting the MRI being blinded to the arthroscopy
result) [29]. Use of blinding of the clinical assessor also
reflects clinical practice where the MR imaging is usually
performed prior to the arthroscopy. The current findings for
sensitivity, specificity, and accuracy in the current study
are certainly within the range of those found in meta-
analyses, are similar to recent studies examining MRI
accuracy for meniscal tears [30–32], and those found in
non-academic clinical practice [30, 33].
A non-monetary outcome of using VSI, not discussed
above, is a potential shortening of the patient’s diagnostic
odyssey. With such a system, the patient is awake and can
review their pathology actively with the physician. This
also engages the patient in the course of diagnosis and
potential treatment, and may reduce any patient anxiety
that results from not knowing.
The use of in-office arthroscopy may also assist the
physician in their preparation (based on better, more
accurate information) for surgical intervention (when nee-
ded). There is likely a benefit of being better prepared as
the clinician can plan and prepare for the appropriate sur-
gical correction. An example of this is allograft tissue,
which must be procured ahead of a surgical procedure, the
use of which cannot be determined inter-operatively. While
not quantified above, this may also shorten the procedure
time, outcome, and costs of the therapeutic procedure.
The issue of unnecessary and inefficient use of services
in healthcare is a major concern for policy makers and
payers [34]. Use of the VSI system in the physician office
setting reduces the need for clinicians to perform ‘defini-
tive diagnostic’ arthroscopy procedures with FP patients
(which typically turn into a surgical arthroscopy based on
recent Medicare data analysis) [6], and any follow-on care
resulting from MRI FN findings.
As it relates to the sensitivity analysis performed, as
seen in Table 9, a systematic review of MRI accuracy,
sensitivities, specificities, positive predictive values, and
Fig. 1 Cohort of patients undergoing diagnosis and therapy for a
medial meniscus tear—VSI cohort. Does not include costs of
complications. APC Ambulatory Payment Classification, CPT
Current Procedural Terminology, FN false negative, NPV negative
predictive values, PPV positive predictive values, PT physical
therapy, TP true positive, VSI VisionScope imaging
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negative predictive values for medial meniscus tears show
values of 86.3 %, 91.4 %, 81.1 %, 83.2 %, and 90.1 %,
respectively [19]. The data used in this meta-analysis [19]
were mainly from academic institutions where MRI
assessment/accuracy of diagnosis is typically better than
what is seen in the community setting. At these ‘academic’
sensitivities and specificities, use of VSI versus MRI still
results in considerable savings to the system, exceeding
US$115 million for diagnosing and treating medial meni-
scal tears. As mentioned, the findings from the MRI/VSI
study (found in Appendix 1 in the ESM) may be more in
line with what is found in a community setting, and the
savings as well. The sensitivity analysis (Table 9) shows
that, in an academic setting with MRI sensitivity and
specificity results versus standard arthroscopy (the gold
standard), the use of VSI in place of MRI results in cost
savings approximately half the time when varying the
sensitivities and specificities higher and lower. The only
times MRI demonstrated a consistent cost savings was
when the MRI sensitivities were \75 % (i.e., when there
was an increased number of FN findings). Since diagnostic
tests are designed to identify disease/pathology when it is
present (e.g., rule in disease), it is unlikely that these cost-
saving findings with a ‘low sensitivity’ (with concurrent
high specificities) from MRI in Table 9 would ever be
realized. Further, as shown in the shaded sections of
Table 9, where most sensitivity and specificity MRI find-
ings are likely to be found for medial meniscus diagnosis
[30, 35, 36], cost savings result when using VSI. Thus, it
can be concluded that the VSI cost savings are robust for
permutations of MRI sensitivity/specificity. Additionally,
as depicted in the Tornado plot (Fig. 5), these cost savings
continue to exist when varying (up or down) factors that
might affect these savings, including the cost of the pro-
cedure, complications, and the number of procedures
(using study data). What is most interesting is that cost
savings were most affected by varying the sensitivity of the
MRI test. At lower MRI sensitivities, less savings resulted
from VSI use and at higher sensitivities, much higher
savings were realized. Since diagnostic tests are designed
to rule in disease (i.e., possess relatively high sensitivities),
it is unlikely that this ‘low sensitivity’ scenario would
Fig. 2 Cohort of patients undergoing diagnosis and therapy for a
medial meniscus tear—MRI cohort. Does not include costs of
complications. APC Ambulatory Payment Classification, CPT
Current Procedural Terminology, FN false negative, NPV negative
predictive values, PPV positive predictive values, PT physical
therapy, TP true positive, VSI VisionScope imaging
Needle Arthroscopy Cost Analysis 531
occur. As well, at lower sensitivities, more patients would
be misdiagnosed as not having a meniscal tear when one
actually exists and thus likely go down a path of inappro-
priate care/treatment.
4.1 Limitations
The following limitations of the above analysis should be
taken into account.
• It assumes the most conservative treatment when a FP
result under MRI was treated with knee procedures (i.e.,
meniscectomy versus repair). This may have underes-
timated the complication rates and costs reported on
above with MRI, as more aggressive treatment may
have been undertaken with these FP findings.
• It assumes that FP MRI results always result in a
surgical arthroscopy procedure. This in turn may have
overestimated the actual costs of the MRI paradigm.
However, in pathology that appears positive under MRI
and is difficult to interpret as in the pathology described
herein (e.g., deep tissue), surgical arthroscopy is
commonly performed.
• Since no ‘good’ data exist in the literature on the
complication rates seen with small needle/single access
site arthroscopy, the complication rate assumed in this
analysis with the VSI procedure was an estimate based
on half of what the complication rate would be with
arthroscopy (i.e., single access versus two access sites
with traditional arthroscopy). In reports of case series
on small needle arthroscopy, none of the complication
rates noted above were seen [15]. The only estimated
complication used with VSI was for infections at a rate
of 0.01 %.
• The use of a full course of PT (6 weeks and 10 visits at
US$1,318) was assumed to be 85 % in the FN, FN CO,
TP, and FP patients. The assumption was that since an
orthopedist prescribed the PT, it was closely adhered to
[23, 27]. Some patients may have taken it upon
themselves to rehab at home, or not undergone PT,
and thus may not have incurred this cost.
• This does not include the costs of pain medications
which may be higher with MRI due to a higher number
of FN findings.
• Analysis utilizes Medicare reimbursement. If private
payer reimbursement were used in place of Medicare,
Fig. 3 Cohort of patients undergoing diagnosis and therapy for a
lateral meniscus tear—VSI cohort. Does not include costs of
complications. APC Ambulatory Payment Classification, CPT
Current Procedural Terminology, FN false negative, NPV negative
predictive values, PPV positive predictive values, PT physical
therapy, TP true positive, VSI VisionScope imaging
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savings would likely be higher as reimbursement is
typically higher with private payers. As an example, as
depicted in Fig. 5, with an increase of 20 % for
reimbursement, the corresponding savings realized in
using VSI would be US$206 million versus US$177
million (at baseline) for medial meniscus pathology.
Table 9 Sensitivity analysis (cost savings in millions if using VSI or MRI)
Positive cost savings represent costs savings for VSI. Negative cost savings identified in parentheses represent cost savings from MRI. Assumes
VSI results are constant for sensitivity and specificity at 94 % and 97 %, respectively
Fig. 4 Cohort of patients undergoing diagnosis and therapy for a
lateral meniscus tear—MRI cohort. Does not include costs of
complications. APC Ambulatory Payment Classification, CPT
Current Procedural Terminology, FN false negative, NPV negative
predictive values, PPV positive predictive values, PT physical
therapy, TP true positive, VSI VisionScope imaging
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5 Conclusion
More frequent use of the VSI system in the physician office
setting as a diagnostic tool may reduce downstream and
unnecessary procedures and costs in deep-seated knee
pathology. Unnecessary procedures are by definition poor
quality of care. Thus, reducing unnecessary procedures
improves quality of care. More widespread utilization of
the VSI diagnostic imaging system could save the US
healthcare system significant dollars—most especially in
medial meniscus pathology. These cost savings may also
translate to other countries that perform arthroscopy pro-
cedures in similar settings (e.g., hospital outpatient setting).
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